Evidence map›Paper›PMID 40686762›Full record

ArticleAmerican journal of ophthalmology case reports2025

Recurrence of hematocornea with intraocular neoplasm.

Oganes Georgievich Oganesyan, Daria Alexandrovna Gusak, Svetlana Vladimirovna Saakyan, Anush Gamletovna Amiryan, Sergey Victorovich Milash, Carolina Oganesyan

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in American journal of ophthalmology case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Oganes Georgievich OganesyanDepartment of Ophthalmology, Crystal Vision Bahrаin Specialist Hospital, Manama, Bahrain.
Daria Alexandrovna GusakDepartment of Ophthalmic Oncology and Radiology, Moscow Helmholtz Research Institute of Eye Diseases, Moscow, Russian Federation.
Svetlana Vladimirovna SaakyanDepartment of Ophthalmic Oncology and Radiology, Moscow Helmholtz Research Institute of Eye Diseases, Moscow, Russian Federation.
Anush Gamletovna AmiryanDepartment of Ophthalmology, Crystal Vision Bahrаin Specialist Hospital, Manama, Bahrain.
Sergey Victorovich MilashDepartment of Ophthalmic Oncology and Radiology, Moscow Helmholtz Research Institute of Eye Diseases, Moscow, Russian Federation.
Carolina OganesyanFaculty of Medicine, The Charles University, Prague, Czech Republic.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Herein, we report a rare case of recurrent hematocornea due to a non-pigmented adenoma of the ciliary body and its successful management with repeated deep anterior lamellar keratoplasty (DALK). Observations: A 27-year-old man presented with significant visual acuity loss in his only functional eye due to hematocornea. Initial management involved visco-DALK, which restored visual acuity to 0.8. After 6 months, recurrent hematocornea prompted the removal of the underlying neoplasm through a scleral approach, which was histologically confirmed as a non-pigmented adenoma of the ciliary body. A repeat DALK was performed, followed by phacoemulsification with intraocular lens implantation for subsequent cataract development. Postoperative recovery was uneventful, and visual acuity stabilized at 0.8. Conclusions and importance: This case highlights the feasibility and efficacy of visco-DALK in managing hematocornea while preserving endothelial integrity. The approach facilitated subsequent interventions, including neoplasm excision, repeat DALK, and cataract surgery, with favorable visual outcomes.

Indexed as

Adenoma of the ciliary bodyCorneal neovascularizationDeep anterior lamellar keratoplastyHematocorneaIntracorneal hemorrhageViscodissection

Identifiers

PMID40686762
PMCPMC12271898

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.